Article

Metabolitin-based molecular drug delivery by targeting GPR158 in glioblastoma

2021-12-13

Abstract excerpt

Glioblastoma multiforme (GBM) is a lethal form of intracranial tumor. One of the obstacles to treat GBM is the blood-brain barrier which limit the transportation of drugs into the tumor site. Here, based on our previous study on metabolitin (MTL) and osteocalcin, we generated a molecular drug delivery system that consisted of metabolitin and small molecules such as fluorescent dye or peptide drugs for diagnosis an...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: ec7b1933-2807-5b50-aeb7-0d8ba8d3619d
DOI: 10.1101/2021.12.13.472376

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Metabolitin-based molecular drug delivery by targeting GPR158 in glioblastomaDOI 10.1101/2021.12.13.472376Read

Development of Integrin α5β1-targeted PET/NIR imaging probes for glioblastoma intraoperative navigation and intracavity targeted radionuclide therapySemantic proximity Read

Machine learning for the micropeptide encoded by LINC02381 regulates ferroptosis through the glucose transporter SLC2A10 in glioblastomaSemantic proximity Read

Unravelling the Glioblastoma Tumour Microenvironment: Can Aptamer Targeted Delivery Become Successful in Treating Brain Cancers?Semantic proximity Read

Harnessing the Power of Sugar-Based Nanoparticles: A Drug-Free Approach to Enhance Immune Checkpoint Inhibition against Glioblastoma and Pancreatic CancerSemantic proximity Read

Systemic delivery of a CXCR4-CXCL12 signaling inhibitor encapsulated in synthetic protein nanoparticles for glioma immunotherapySemantic proximity Read

Harnessing the Cross-talk between Tumor Cells and Tumor-associated Macrophages with a Nano-drug for modulation of Glioblastoma Immune MicroenvironmentSemantic proximity Read

NDRG1 and its family members: More than just metastasis suppressor proteins and targets of thiosemicarbazonesSemantic proximity Read

Gamabufotalin induces a negative feedback loop connecting ATP1A3 expression and the AQP4 pathway to promote temozolomide sensitivity in glioblastoma cells by targeting the amino acid Thr794Semantic proximity Read

A novel ANG-BSA/BCNU/ICG MNPs integrated for targeting therapy of glioblastomaSemantic proximity Read

Nuclear medicine and molecular imaging advances in the 21st centurySemantic proximity Read

Targeting CD146 with a 64Cu-labeled antibody enables in vivo immunoPET imaging of high-grade gliomas.Semantic proximity Read

Glutamate Receptors and Glioblastoma Multiforme: An Old “Route” for New PerspectivesSemantic proximity Read